Citius pharmaceuticals receives fda response and guidance to pre-ind consultation submission for mino-wrap

Cranford, n.j., dec. 9, 2020 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced its receipt of a written response and guidance from the...
CTXR Ratings Summary
CTXR Quant Ranking